Navigation Links
Bioniche Reports the Passing of its Board Chair
Date:4/18/2008

- Hy Isenbaum served as Chair of the Bioniche Board of Directors since 1999

-

BELLEVILLE, ON, April 18 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that its long-time Board Chair, Mr. Hy Isenbaum, has passed away.

"This is very sad news for Bioniche Life Sciences," said Graeme McRae, the Company's President & CEO. "As Board Chair, Mr. Isenbaum contributed financial expertise and vigilance regarding the Company's financial statements. Additionally, he has provided a high level, conservative, ethical tone that permeates the whole Company in terms of regulatory affairs, product development, and overall conduct of the business. He will be greatly missed by all who knew and worked with him. He was a mentor and a friend."

Mr. Isenbaum was Chair of the Board since 1999, when Bioniche Life Sciences Inc. was formed through an amalgamation of Bioniche Inc., Renaissance Life Sciences Inc., and Vetrepharm Animal Health Inc.

Mr. Isenbaum was a Fellow Chartered Accountant and the Founder of the firm Soberman, Isenbaum and Colomby. As the Managing Partner, a position he held until 1993, he built his firm to be the 15th largest accounting practice in Canada. He was a Chairman of the Board and Chairman Emeritus of the Mount Sinai Hospital in Toronto. He was appointed by the Ontario Ministry of Health as Ombudsman to the Medical Review Committee of the College of Physicians and Surgeons. He served on the Board of Directors of the Samuel Lumenfeld Research Institute in Toronto and was instrumental in the establishment of the Institute. Mr. Isenbaum was also a Governor of the Weizman Institute of Science in Israel and sat on the boards of a number of private and public companies.

In honour of Mr. Isenbaum's extensive contributions to Bioniche, the "Hy Isenbaum Award" has been created. This will be presented annually to the Bioniche employee who best epitomizes the Bioniche spirit - whether at work or in the community.

A new Chair will be appointed at the Board's next quarterly meeting in early May.

About Bioniche Life Sciences Inc.

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 200 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. Bioniche has been named one of Canada's Top Ten Life Sciences Companies for 2008. For more information, please visit http://www.Bioniche.com.

Except for historical information, this news release may contain forward-looking statements that reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process, and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting.


'/>"/>
SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Bioniche Converts a Portion of its Debt to Equity
2. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
3. Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
4. Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
5. Bioniche Reports Fiscal 2008 Second Quarter
6. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
7. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
8. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
9. Bioniche Reports Fiscal 2008 First Quarter
10. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
11. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... 2016 , ... In honor of National Physical Fitness and Sports Month in ... their fitness journey on social media. , The foot care company, which specializes ... product voucher each week during May to one winner. , “Whether the goal is ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... Huntington Beach, California announced today the release of Grow Healthy Vending’s newly revamped ... one of the fastest growing healthy vending providers in North America with locations ...
(Date:5/2/2016)... ... 2016 , ... Over $60 Billion is spent annually on products for our ... product review site for Toys, Tots, Pets & More (TTPM) announced the 15 winners ... at the Metropolitan Pavilion in New York City. , Chosen from a field of ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... MedPro Waste ... mail back service. MedPro now offers its mail back service for an all-inclusive ... we are now able to provide service to all of the clients in the ...
(Date:5/2/2016)... ... May 02, 2016 , ... Further establishing itself as ... that the new WHIMZEES Variety Value Boxes were selected from over 1,000 entrants as ... Award. , WHIMZEES natural dental chews for dogs are a favorite product among ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... , April 29, 2016 ... Life Sciences, Product Development Capabilities in ... Customer Base . Indegene ( ... announced the acquisition of Skura Corporation,s life science ... in adaptive sales enablement technology for life science ...
(Date:4/28/2016)... YORK , April 28, 2016  While ... notably complement the company,s valve repair and stent ... move also places Abbott more firmly into patient ... of the fastest growing device areas, with double-digit ... its recent report,  Advanced Remote Patient Monitoring ...
(Date:4/28/2016)... , April 28, 2016 ... consumer insights on healthcare, announced today that it has ... report Cool Vendor in Life Sciences, 2016, ... 15, 2016.  The report focuses on life-science- oriented analytics, ... insight from patients and doctors, confirm medication ingestion, and ...
Breaking Medicine Technology: